1. Pharmacodynamic modelling and exposure–response assessment of inebilizumab in subjects with neuromyelitis optica spectrum disorders. Issue 8 (5th April 2022) Authors: Yan, Li; Wang, Bing; She, Dewei; Mitchell, Ben; Criste, Ryan; Cimbora, Daniel; Katz, Eliezer; Rees, William A. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 8(2022) Page Start: 3803 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗